- About Us
- Career Center
- Nano-Social Network
- Nano Consulting
- My Account
March 27th, 2006
A small band of researchers scattered around the country from East Tennessee State University to Harvard's Brigham and Women's Hospital are about to test a new, nanotech approach to heading off a potential bird flu pandemic.
The scientists are developing liposomes, fatty globules used as a tiny drug delivery device, which contain a mix of antioxidants and anti-viral drugs. The researchers believe that these liposomes, which can be reduced to a size as small as 25 to 50 nanometers, can cripple the lethal chain reaction that allows a virus to replicate, saving the patient.
|Related News Press|
Healthcare Nanotechnology (Nanomedicine) Market Size To 2020 June 5th, 2015
Leti Announces Launch of First European Nanomedicine Characterisation Laboratory: Project Combines Expertise of 9 Partners in 8 Countries to Foster Nanomedicine Innovation and Facilitate Regulatory Approval July 1st, 2015
Producing spin-entangled electrons July 2nd, 2015